Details for New Drug Application (NDA): 210697
✉ Email this page to a colleague
The generic ingredient in PHENYLEPHRINE HYDROCHLORIDE is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.
Summary for 210697
| Tradename: | PHENYLEPHRINE HYDROCHLORIDE |
| Applicant: | Eugia Pharma |
| Ingredient: | phenylephrine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 210697
| Mechanism of Action | Adrenergic alpha1-Agonists |
Medical Subject Heading (MeSH) Categories for 210697
Suppliers and Packaging for NDA: 210697
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 210697 | ANDA | Eugia US LLC | 55150-301 | 55150-301-10 | 10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-301-10) / 5 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-301-01) |
| PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 210697 | ANDA | Eugia US LLC | 55150-302 | 55150-302-01 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-302-01) / 10 mL in 1 VIAL, PHARMACY BULK PACKAGE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/5ML (10MG/ML) | ||||
| Approval Date: | Nov 13, 2020 | TE: | AP1 | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 100MG/10ML (10MG/ML) | ||||
| Approval Date: | Nov 13, 2020 | TE: | AP1 | RLD: | No | ||||
Complete Access Available with Subscription
